SCHEMBL23555763

SCHEMBL23555763

Cc1nc2ncc(Br)cc2c(=O)n1Cc1ccc(Cl)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.54
▸ SMN1; SMN2 Q16637 4/20 0.54
▸ KDM4E B2RXH2 4/20 0.54
▸ HSD17B10 Q99714 2/20 0.54
▸ HPGD P15428 1/20 0.54
▸ MEN1 O00255 4/20 0.50
▸ KMT2A Q03164 4/20 0.50
▸ LMNA P02545 3/20 0.48
▸ HDAC3 O15379 1/20 0.48
▸ HDAC4 P56524 1/20 0.48
▸ HDAC1 Q13547 1/20 0.48
▸ HDAC7 Q8WUI4 1/20 0.48
▸ HDAC2 Q92769 1/20 0.48
▸ HDAC10 Q969S8 1/20 0.48
▸ HDAC11 Q96DB2 1/20 0.48
▸ HDAC8 Q9BY41 1/20 0.48
▸ HDAC6 Q9UBN7 1/20 0.48
▸ HDAC9 Q9UKV0 1/20 0.48
▸ HDAC5 Q9UQL6 1/20 0.48
▸ NPC1 O15118 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22516485 0.82 GALR3 (0.51) ALDH1A1SMN1; SMN2KDM4EHSD17B10HPGD
SCHEMBL23555769 0.81 KDM4E (0.55) ALDH1A1SMN1; SMN2KDM4EHSD17B10HPGD
SCHEMBL23555767 0.77 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2KDM4EHSD17B10HPGD
SCHEMBL23555556 0.76 TP53 (0.57) SMN1; SMN2MEN1KMT2ALMNAHDAC6
SCHEMBL23555766 0.75 KDM4E (0.51) ALDH1A1SMN1; SMN2KDM4EHSD17B10HPGD
SCHEMBL23555765 0.75 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2KDM4EHSD17B10HPGD
SCHEMBL15215746 0.73 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2KDM4EHSD17B10HPGD
SCHEMBL23555541 0.72 ALDH1A1 (0.62) ALDH1A1SMN1; SMN2KDM4EHSD17B10HPGD
SCHEMBL23555535 0.71 ALDH1A1 (0.60) ALDH1A1SMN1; SMN2KDM4EHSD17B10HPGD
SCHEMBL17807866 0.70 TNF (0.52) ALDH1A1KDM4EHPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021127071-A1 BICYCLIC HETEROCYCLE COMPOUNDS METHODS OF USE THEREOF FOR THE TREATMENT OF HERPES VIRUSES MERCK SHARP & DOHME CORP. (US) 2021-06-24 — — WO disclosed
Send feedback